FDA Issues 2025-26 Flu Vaccine Recommendations Without Independent Adviser Input
17 Mar 2025
The U.S. Food and Drug Administration (FDA) recently announced its recommendations for the composition of the 2025-26 influenza vaccine, making this decision without the usual input from its independent vaccine advisers. This move follows the unexpected cancellation of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which...
Read More
